Marshall Wace, LLP Qiagen N.V. Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$39.13 - $47.24 $16.3 Million - $19.7 Million	-417,487 Reduced 15.73%	2,236,296 $90.6 Million
Q2 2023 Aug 14, 2023	BUY	$43.93 - $46.76 $22.9 Million - $24.4 Million	522,140 Added 24.49%	2,653,783 $119 Million
Q1 2023 May 15, 2023	SELL	$45.29 - $50.76 $3.71 Million - $4.16 Million	-81,899 Reduced 3.7%	2,131,643 $97.9 Million
Q4 2022 Feb 14, 2023	SELL	$41.91 - $50.48 $5.79 Million - $6.97 Million	-138,096 Reduced 5.87%	2,213,542 $110 Million
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $5.88 Million - $7.25 Million	143,843 Added 6.52%	2,351,638 $98.9 Million

Q2 2022 Aug 15, 2022	BUY	$42.98 - $49.77 $12.9 Million - $15 Million	300,973 Added 15.78%	2,207,795 $103 Million
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $43 Million - $55.3 Million	1,018,390 Added 114.63%	1,906,822 $94.4 Million
Q4 2021 Feb 14, 2022	BUY	$50.62 - $56.47 $33.3 Million - $37.1 Million	656,906 Added 283.73%	888,432 $49.5 Million
Q3 2021 Nov 15, 2021	SELL	$46.55 - $56.83 $4.18 Million - $5.1 Million	-89,742 Reduced 27.93%	231,526 $12 Million
Q2 2021 Aug 13, 2021	BUY	$46.28 - $52.75 $6.95 Million - $7.92 Million	150,162 Added 87.76%	321,268 $15.5 Million
Q1 2021 May 17, 2021	SELL	$46.25 - $56.02 $15.3 Million - $18.5 Million	-330,730 Reduced 65.9%	171,106 $8.3 Million
Q4 2020 Feb 16, 2021	SELL	$46.09 - $54.74 $20 Million - $23.8 Million	-434,643 Reduced 46.41%	501,836 $26.1 Million
Q3 2020 Nov 16, 2020	BUY	$42.51 - $52.42 $21.5 Million - $26.6 Million	506,518 Added 117.81%	936,479 $48.7 Million
Q2 2020 Aug 13, 2020	BUY	$39.49 - $44.36 $9.32 Million - $10.5 Million	236,066 Added 121.75%	429,961 $18.5 Million
Q1 2020 May 15, 2020	SELL	$33.17 - $41.6 $1.85 Million - $2.32 Million	-55,762 Reduced 22.34%	193,895 $7.81 Million
Q4 2019 Feb 14, 2020	SELL	$25.41 - $43.1 $26.9 Million - $45.6 Million	-1,058,305 Reduced 80.91%	249,657 $8.5 Million
Q3 2019 Nov 14, 2019	BUY	$32.73 - $40.81 $16.9 Million - $21.1 Million	516,163 Added 65.19%	1,307,962 $42.9 Million
Q2 2019 Aug 14, 2019	BUY	$35.73 - $41.39 $13.8 Million - $16 Million	386,635 Added 95.43%	791,799 $32.2 Million
Q1 2019 May 14, 2019	BUY	$33.78 - $40.68 $13.7 Million - $16.5 Million	405,164 New	405,164 $16.5 Million
Q4 2018 Feb 14, 2019	SELL	$32.65 - $37.95 $3.59 Million - $4.18 Million	-110,101 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$35.99 - $39.39 $11.9 Million - $13 Million	-330,640 Reduced 75.02%	110,101 $4.17 Million
Q2 2018 Aug 14, 2018	SELL	$31.23 - $37.47 $4.46 Million - $5.36 Million	-142,936 Reduced 24.49%	440,741 $16.1 Million
Q1 2018 May 15, 2018	SELL	$31.01 - $34.72 $26.9 Million - $30.1 Million	-866,730 Reduced 59.76%	583,677 $18.8 Million
Q4 2017 Feb 14, 2018	BUY	$30.68 - $35.37 $44.5 Million - $51.3 Million	1,450,407	1,450,407 $45.6 Million

Others Institutions Holding QGEN

# of Institutions

Shares Held

6.76M

Call Options Held

Put Options Held

Pendal Group LTD

4.3M
Shares

$177 Million
1.76% of portfolio
Abeille Asset Management Sa

931K
Shares

$38.3 Million
1.68% of portfolio
Grandeur Peak Global Advisors, LLC Salt Lake City, UT

768K
Shares

$31.6 Million
2.68% of portfolio
Nuveen Asset Management, LLC Chicago, IL

345K
Shares

$14.2 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

153K
Shares

$6.31 Million
0.01% of portfolio

View Full List

About QIAGEN N.V.

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.36B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

More about QGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account